Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Alia Biotech

+1 (818) 909-9808
Website

Advertisement

Advertisement

3039 W Valley Blvd
Alhambra, CA 91803
+1 (818) 909-9808
https://www.aliabiotech.com

ALiA BioTech, formerly known as Sanwa BioTech, is a leading provider of accurate and actionable diagnostic information through their Point-Of-Care Testing (POCT) platform and BioChip technology.

Their focus is on enabling faster clinical decisions and improving economic outcomes for their clients by offering innovative testing solutions.

Generated from their website's infomation

Also at this address

Los Rolling Servicios Gates

Garage Door Opener Repair

Verdugo Plaza Pharmacy Alhambra

yelp logo
1 reviews
Own this business?
Claim it
See a problem?

You might also like

Sensorygen, Inc

Sensorygen, Inc is a cutting-edge company based in South Pasadena, CA that specializes in the development of innovative technologies. Their expertise lies in InsectsAI, SensoryAI, and ToxAI, which are revolutionizing various industries through advanced sensory and artificial intelligence solutions. With a focus on discovery partnerships, Sensorygen collaborates with organizations to create groundbreaking solutions that address complex challenges. Their California headquarters serve as a hub for their groundbreaking research and development efforts, positioning them at the forefront of technological advancements.Generated from the website
Epeius Biotechnologies Corporation
Biotechnical research, noncommercial

Epeius Biotechnologies Corporation

This biotech firm specializes in the research and treatment of cancer. From the development of Rexin-G and Rexximune-C treatments to clinical trials, Epeius is devoted to treating metastatic cancer. Call for an appointment.
Drugs and drug proprietaries

Balto Pharmaceuticals Inc

Balto Pharmaceuticals Inc, based in South Pasadena, CA, is a drug discovery company specializing in small molecule inhibitors and degraders of protein-protein interactions (PPIs) for the treatment of cancer and other diseases. Their proprietary PP2D platform has enabled the discovery of first-in-class small molecules that inhibit and degrade critical drivers in cancer, potentially offering a new class of therapeutics. With a focus on monovalent targeted protein degraders, Balto Pharmaceuticals' PPI inhibitors, isolated through their PP2D platform, show promise in disrupting and degrading PPIs, presenting a novel approach to treating various diseases. Their commitment to innovative drug discovery positions them at the forefront of developing transformative therapies.Generated from the website
United States›California›Alhambra›Alia Biotech

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell